Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.16
Delayed Data
As of Sep 22
 -0.02 / -0.92%
Today’s Change
1.81
Today|||52-Week Range
3.15
+4.35%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close2.18
Today’s open2.17
Day’s range2.14 - 2.20
Volume527,436
Average volume (3 months)1,170,254
Market cap$343.9M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc+0.01+0.36%
EDGEEdge Therapeutics In...+0.02+0.21%
AGENAgenus Inc0.000.00%
BLCMBellicum Pharmaceuti...+0.12+1.06%
Data as of 7:59pm ET, 09/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts